Table 2. Cross tabulation between PSA and histopathological findings.
| Histopathological findings | Total | ||
|---|---|---|---|
| BPH | Prostat Cancer | ||
| PSA ≥ Cut-off | 11(20,8%) | 9(17,0%) | 20(37,7%) |
| PSA ≤ Cut-off | 29(54,7%) | 4(7,5%) | 33(62,3%) |
| Total | 40(24,5%) | 13(24,5%) | 53(100%) |
| Histopathological findings | Total | ||
|---|---|---|---|
| BPH | Prostat Cancer | ||
| PSA ≥ Cut-off | 11(20,8%) | 9(17,0%) | 20(37,7%) |
| PSA ≤ Cut-off | 29(54,7%) | 4(7,5%) | 33(62,3%) |
| Total | 40(24,5%) | 13(24,5%) | 53(100%) |